drugset / Trial / NCT00686335
A New Modified-release Tablet Formulation of Prednisone (Lodotra®) in Patients With Nocturnal Asthma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate in subjects suffering from nocturnal asthma, the efficacy and safety of modified release Prednisone on signs and symptoms.
Timeline
- Start
- 2008-06
- Primary completion
- 2010-03
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prednisone | Other / unclassified | 1 mg | — |
| Comparator | Prednisone | Other / unclassified | 5 mg | — |
| Comparator | Prednisone | Other / unclassified | 1 mg | — |
| Comparator | Prednisone | Other / unclassified | 5 mg | — |